Albrioza
![Amylyx’s Albrioza rejected by EU for ALS](https://pharmtales.com/wp-content/uploads/2023/10/EU-regulator-denies-approval-for-Amylyxs-Albrioza-a-potential-ALS-treatment.jpg)
EU regulator denies approval for Amylyx’s Albrioza, a potential ALS treatment
Anika Sharma
While Amylyx’s ALS drug, known as Albrioza in Europe and Relyvrio in the US, has made significant strides in the ...
![Regulatory Update: Amylyx's ALS drug faces rejection by the European Medicines Agency (EMA)](https://pharmtales.com/wp-content/uploads/2023/06/Regulatory-Update_-Amylyxs-ALS-drug-faces-rejection-by-the-European-Medicines-Agency-EMA.jpg)
Regulatory Update: Amylyx’s ALS drug faces rejection by the European Medicines Agency (EMA)
SG Tylor
Source – Amylyx Pharmaceuticals On June 23, 2023, the European Medicines Agency (EMA) has formally issued a negative opinion regarding ...